Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Consolidated Statements of Changes in Shareholders' Equity

v3.19.3.a.u2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common shares
Warrants
Contributed surplus
Deficit
Accumulated other comprehensive loss
Equity, opening balance at Dec. 31, 2017 $ 165,821 $ 499,200 $ 906 $ 18,360 $ (351,840) $ (805)
Exercise of derivative warrants 3,071 3,977 (906)      
Exercise of stock options 943 1,473   (530)    
Stock-based compensation 6,860     6,860    
Net loss and comprehensive loss for the year (64,120)       (64,120)  
Equity, closing balance at Dec. 31, 2018 112,575 504,650 0 24,690 (415,960) (805)
Issue of common shares 236,747 236,747        
Share issue costs (13,629) (13,629)        
Exercise of derivative warrants 40,507 40,507 (906)      
Exercise of stock options 13,748 22,197   (8,449)    
Stock-based compensation 7,414     7,414    
Net loss and comprehensive loss for the year (123,846)          
Equity, closing balance at Dec. 31, 2019 $ 273,516 $ 790,472 $ 0 $ 23,655 $ (539,806) $ (805)